Related references
Note: Only part of the references are listed.Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Cardiac Arrhythmias in Autoimmune Diseases
Monika Gawalko et al.
CIRCULATION JOURNAL (2020)
Cardiovascular complications in COVID-19
Brit Long et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2020)
Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society
John L. Sapp et al.
CANADIAN JOURNAL OF CARDIOLOGY (2020)
COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options
Tomasz J. Guzik et al.
CARDIOVASCULAR RESEARCH (2020)
Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection
Moussa Saleh et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2020)
Could Chloroquine/Hydroxychloroquine Be Harmful in Coronavirus Disease 2019 (COVID-19) Treatment?
Maurizio Guastalegname et al.
CLINICAL INFECTIOUS DISEASES (2020)
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Xueting Yao et al.
CLINICAL INFECTIOUS DISEASES (2020)
QTc evaluation in COVID-19 patients treated with chloroquine/hydroxychloroquine
Alice Monzani et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2020)
Cardiovascular manifestations and treatment considerations in COVID-19
Yu Kang et al.
HEART (2020)
QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin
Ehud Chorin et al.
HEART RHYTHM (2020)
Chloroquine-induced torsades de pointes in a patient with coronavirus disease 2019
Yishay Szekely et al.
HEART RHYTHM (2020)
Hydroxychloroquine and Azithromycin to Treat Patients With COVID-19: Both Friends and Foes?
Bruno Megarbane et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Chloroquine-induced QTc prolongation in COVID-19 patients
M. P. H. van den Broek et al.
NETHERLANDS HEART JOURNAL (2020)
Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
Mandeep R Mehra et al.
LANCET (2020)
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Jia Liu et al.
CELL DISCOVERY (2020)
Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China
Joseph T. Wu et al.
NATURE MEDICINE (2020)
Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19)
Katelyn A. Pastick et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety
Kamalan Jeevaratnam
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2020)
Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection A Randomized Clinical Trial
Mayla Gabriela Silva Borba et al.
JAMA NETWORK OPEN (2020)
COVID-19: Therapeutics and Their Toxicities
Michael A. Chary et al.
JOURNAL OF MEDICAL TOXICOLOGY (2020)
Toxicokinetics of hydroxychloroquine following a massive overdose
Jonathan de Olano et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2019)
Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria
Cindy S. Chu et al.
CLINICAL INFECTIOUS DISEASES (2018)
Risk of sudden unexplained death after use of dihydroartemisinin-piperaquine for malaria: a systematic review and Bayesian meta-analysis
Xin Hui S. Chan et al.
LANCET INFECTIOUS DISEASES (2018)
Mechanistic Model-Informed Proarrhythmic Risk Assessment of Drugs: Review of the CiPA Initiative and Design of a Prospective Clinical Validation Study
Jose Vicente et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Stan: A Probabilistic Programming Language
Bob Carpenter et al.
JOURNAL OF STATISTICAL SOFTWARE (2017)
Population pharmacokinetics of a three-day chloroquine treatment in patients with Plasmodium vivax infection on the Thai-Myanmar border
Richard Hoeglund et al.
MALARIA JOURNAL (2016)
Electrocardiographic Findings in Systemic Lupus Erythematosus: Data From an International Inception Cohort
Josiane Bourre-Tessier et al.
ARTHRITIS CARE & RESEARCH (2015)
Pharmacokinetic Interactions between Primaquine and Chloroquine
Sasithon Pukrittayakamee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Evidence for cardiac safety and antiarrhythmic potential of chloroquine in systemic lupus erythematosus
Ricardo Alkmim Teixeira et al.
EUROPACE (2014)
Chloroquine cardiomyopathy - a review of the literature
Ernst Toennesmann et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2013)
Blood concentrations are better predictors of chioroquine poisoning severity than plasma concentrations: a prospective study with modeling of the concentration/effect relationships
Bruno Megarbane et al.
CLINICAL TOXICOLOGY (2010)
Survival after massive hydroxychloroquine overdose
N. Gunja et al.
ANAESTHESIA AND INTENSIVE CARE (2009)
Emergency feasibility in medical intensive care unit of extracorporeal life support for refractory cardiac arrest
Bruno Megarbane et al.
INTENSIVE CARE MEDICINE (2007)
Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia
CY Chen et al.
CLINICAL TOXICOLOGY (2006)
The cardiac safety of chloroquine phosphate treatment in patients with systemic lupus erythematosus: the influence on arrhythmia, heart rate variability and repolarization parameters
A. Wozniacka et al.
LUPUS (2006)
Chloroquine poisoning in Zimbabwe: a toxicoepidemiological study
DE Ball et al.
JOURNAL OF APPLIED TOXICOLOGY (2002)
Share Paper
